Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Environmental radon exposure and breast cancer risk in the Nurses' Health Study II.

VoPham T, DuPré N, Tamimi RM, James P, Bertrand KA, Vieira V, Laden F, Hart JE.

Environ Health. 2017 Sep 7;16(1):97. doi: 10.1186/s12940-017-0305-6.

2.

Analysis of genes involved in the PI3K/Akt pathway in radiation- and MNU-induced rat mammary carcinomas.

Showler K, Nishimura M, Daino K, Imaoka T, Nishimura Y, Morioka T, Blyth BJ, Kokubo T, Takabatake M, Fukuda M, Moriyama H, Kakinuma S, Fukushi M, Shimada Y.

J Radiat Res. 2017 Mar 1;58(2):183-194. doi: 10.1093/jrr/rrw097.

3.

Mechanism of irradiation-induced mammary cancer metastasis: A role for SAP-dependent Mkl1 signaling.

Asparuhova MB, Secondini C, Rüegg C, Chiquet-Ehrismann R.

Mol Oncol. 2015 Oct;9(8):1510-27. doi: 10.1016/j.molonc.2015.04.003. Epub 2015 Apr 30.

4.

Crucial role for early growth response-1 in the transcriptional regulation of miR-20b in breast cancer.

Li D, Ilnytskyy Y, Kovalchuk A, Khachigian LM, Bronson RT, Wang B, Kovalchuk O.

Oncotarget. 2013 Sep;4(9):1373-87.

5.

Combining mTOR inhibition with radiation improves antitumor activity in bladder cancer cells in vitro and in vivo: a novel strategy for treatment.

Nassim R, Mansure JJ, Chevalier S, Cury F, Kassouf W.

PLoS One. 2013 Jun 17;8(6):e65257. doi: 10.1371/journal.pone.0065257. Print 2013.

7.

Female breast cancer in relation to exposure to medical iatrogenic diagnostic radiation during life.

Gledo I, Pranjic N, Drljević K, Prasko S, Drljevic I, Brzeziński P.

Contemp Oncol (Pozn). 2012;16(6):551-6. doi: 10.5114/wo.2012.32489. Epub 2013 Jan 4.

8.

p53 Ser15 phosphorylation and histone modifications contribute to IR-induced miR-34a transcription in mammary epithelial cells.

Wang B, Li D, Kovalchuk O.

Cell Cycle. 2013 Jul 1;12(13):2073-83. doi: 10.4161/cc.25135. Epub 2013 Jun 6.

9.

Effects of radiation exposure from cardiac imaging: how good are the data?

Einstein AJ.

J Am Coll Cardiol. 2012 Feb 7;59(6):553-65. doi: 10.1016/j.jacc.2011.08.079. Review.

10.

Cost-effective screening for breast cancer worldwide: current state and future directions.

Sarvazyan A, Egorov V, Son JS, Kaufman CS.

Breast Cancer (Auckl). 2008;1:91-9. Epub 2008 Jul 2.

11.

Breast cancer incidence following low-dose rate environmental exposure: Techa River Cohort, 1956-2004.

Ostroumova E, Preston DL, Ron E, Krestinina L, Davis FG, Kossenko M, Akleyev A.

Br J Cancer. 2008 Dec 2;99(11):1940-5. doi: 10.1038/sj.bjc.6604775. Epub 2008 Nov 11.

12.

Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors.

Hill DA, Gilbert E, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Wiklund T, Lynch CF, Van't Veer M, Storm H, Pukkala E, Stovall M, Curtis RE, Allan JM, Boice JD, Travis LB.

Blood. 2005 Nov 15;106(10):3358-65. Epub 2005 Jul 28.

13.

Radiation and breast cancer: a review of current evidence.

Ronckers CM, Erdmann CA, Land CE.

Breast Cancer Res. 2005;7(1):21-32. Epub 2004 Nov 23. Review.

14.

Ionizing radiation induces heritable disruption of epithelial cell interactions.

Park CC, Henshall-Powell RL, Erickson AC, Talhouk R, Parvin B, Bissell MJ, Barcellos-Hoff MH.

Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10728-33. Epub 2003 Sep 5.

15.

Dose- and time-response for breast cancer risk after radiation therapy for benign breast disease.

Mattsson A, Rudén BI, Palmgren J, Rutqvist LE.

Br J Cancer. 1995 Oct;72(4):1054-61.

Supplemental Content

Support Center